MYL just raised capital at 7 cents, probably with the selling point they will be issuing a scoping study if the scoping study is not announced, many placement takers who are short term profit takers will take a 10% loss & move on
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025